Sarsia

Sarsia is an early-stage venture capital firm based in Bergen, Norway, focused on investing in science-based technology companies. Founded in 2006, the firm targets sectors such as biotechnology and life sciences, energy and cleantech, technology, and sustainability. Its team combines operational, business, and technical expertise and maintains a broad national and international network of industry players and co-investors to support portfolio companies through vetting and ongoing growth. Sarsia pursues a selective investment approach with a strong emphasis on entrepreneurship and applied research to bridge research and commercialization.

Jon Berg

Partner

Sveinung Hole

Senior Partner

Past deals in Norway

Heimdall Power

Series B in 2024
Heimdall Power AS, established in Bergen, Norway in 2015, specializes in developing innovative sensor platforms for power grids. Their flagship product, Neuron, monitors transmission lines and distribution feeders in real-time, providing situational awareness through features such as line monitoring, fault detection, dynamic line rating, and advanced analytics. By installing these sensors on power lines to collect data on parameters like temperature, load, and line sag, Heimdall Power enables grid owners to optimize operations, enhance reliability, facilitate the transition to renewable energy sources, and ultimately improve overall grid performance.

Heimdall Power

Venture Round in 2021
Heimdall Power AS, established in Bergen, Norway in 2015, specializes in developing innovative sensor platforms for power grids. Their flagship product, Neuron, monitors transmission lines and distribution feeders in real-time, providing situational awareness through features such as line monitoring, fault detection, dynamic line rating, and advanced analytics. By installing these sensors on power lines to collect data on parameters like temperature, load, and line sag, Heimdall Power enables grid owners to optimize operations, enhance reliability, facilitate the transition to renewable energy sources, and ultimately improve overall grid performance.

Heimdall Power

Venture Round in 2020
Heimdall Power AS, established in Bergen, Norway in 2015, specializes in developing innovative sensor platforms for power grids. Their flagship product, Neuron, monitors transmission lines and distribution feeders in real-time, providing situational awareness through features such as line monitoring, fault detection, dynamic line rating, and advanced analytics. By installing these sensors on power lines to collect data on parameters like temperature, load, and line sag, Heimdall Power enables grid owners to optimize operations, enhance reliability, facilitate the transition to renewable energy sources, and ultimately improve overall grid performance.

Sonoclear AS

Venture Round in 2018
Sonoclear AS, founded in 2016 and based in Trondheim, Norway, specializes in the manufacturing of SonoClear®, an acoustic coupling fluid designed for brain tumor surgery. This innovative product enhances ultrasound imaging by eliminating image artifacts that typically occur in resection cavities. By improving the clarity of surgical images, SonoClear® supports healthcare professionals in making informed clinical decisions during procedures. The company is focused on advancing surgical techniques and outcomes in the field of neurosurgery through its specialized technology.

APIM Therapeutics

Venture Round in 2012
APIM Therapeutics develops innovative peptide drugs targeting Proliferating Cell Nuclear Antigen (PCNA), a key protein regulating cellular responses to DNA damage and stress in cancer cells. Founded on groundbreaking research from NTNU, Trondheim, Norway, the company aims to eliminate and cure cancer-specific tumor cells.

APIM Therapeutics

Venture Round in 2011
APIM Therapeutics develops innovative peptide drugs targeting Proliferating Cell Nuclear Antigen (PCNA), a key protein regulating cellular responses to DNA damage and stress in cancer cells. Founded on groundbreaking research from NTNU, Trondheim, Norway, the company aims to eliminate and cure cancer-specific tumor cells.

Avexxin

Venture Round in 2011
Avexxin's therapeutic approach is built on more than a decade of research into the biological mechanisms involved in inflammatory diseases at the Norwegian University of Science and Technology. Avexxin's goal is to create a therapeutic company based on the discovery and development of novel therapeutics that address the fundamental mechanisms involved in inflammatory diseases.

WindSim

Venture Round in 2007
WindSim AS is a company based in Tonsberg, Norway, specializing in software for simulating wind resources in complex terrains. It offers a product known as WindSim, which optimizes energy production from wind turbines across Europe, Asia, Australia, and North America. The software leverages advanced computational fluid dynamics and automated deep neural learning technologies to enhance the efficiency of energy projects by accurately forecasting energy production. In addition to its software solutions, WindSim provides consulting and training services to help clients effectively utilize its products. The company's offerings are distributed in various countries, including China, France, Germany, Italy, Spain, and Taiwan. WindSim AS was previously named VECTOR AS before adopting its current name in December 2005.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.